Nutritional polypill trial in well subjects in order to assess genome damage
A polypill vs placebo trial to assess genome damage in well subjects
NHMRC
250 participants
Oct 1, 2007
Interventional
Conditions
Summary
This study investigates the potential benefit of supplementary vitamins and essential minerals in the prevention of breaks in cellular DNA, which are associated with cancer development.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intervention: 2 small tablets + 1 capsule, taken simultaneously, daily, orally; Contents: vitamins (B12, E, A, B3) and essential nutrients (folate, calcium); Duration: 16 weeks; Exposure: lifestyle, ageing, nutrition practices.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000651482